TrialClinical breast cancer2016

Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study.

Kari B Wisinski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.